YBX1 and plasma cell myeloma: To summarize, overexpression of YB-1 was associated with poor prognoses in ovarian, lung, breast, prostate, bladder, head and neck cancers, as well as in multiple myelomas and melanomas (with corrected or COX P-values < 0.05).